Loading
Latest filing published 28 Jul 2017 for Tvardi Therapeutics, Inc., €7,674.
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This profile gathers the share dealings of Josef Schoell in Tvardi Therapeutics, Inc. We count 6 filings; the first trade dates from 14 August 2014 and the latest from 26 July 2017.
On the open market, the record shows 1 purchase worth €60k and 1 sale worth €145k. Sales outweigh purchases by €85k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 4 option exercises.
The record was last updated on 28 July 2017 with an option exercise (€7,674) in Tvardi Therapeutics, Inc. The most recent open-market purchase was published on 19 August 2015, 4,085 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations